Results and adverse events of personalized peptide receptor radionuclide therapy with 90Yttrium and 177Lutetium in 1048 patients with neuroendocrine neoplasms.
about
Results and adverse events of personalized peptide receptor radionuclide therapy with 90Yttrium and 177Lutetium in 1048 patients with neuroendocrine neoplasms.
description
2018 nî lūn-bûn
@nan
2018年の論文
@ja
2018年学术文章
@wuu
2018年学术文章
@zh
2018年学术文章
@zh-cn
2018年学术文章
@zh-hans
2018年学术文章
@zh-my
2018年学术文章
@zh-sg
2018年學術文章
@yue
2018年學術文章
@zh-hant
name
Results and adverse events of ...... with neuroendocrine neoplasms.
@en
Results and adverse events of ...... with neuroendocrine neoplasms.
@nl
type
label
Results and adverse events of ...... with neuroendocrine neoplasms.
@en
Results and adverse events of ...... with neuroendocrine neoplasms.
@nl
prefLabel
Results and adverse events of ...... with neuroendocrine neoplasms.
@en
Results and adverse events of ...... with neuroendocrine neoplasms.
@nl
P2093
P2860
P356
P1433
P1476
Results and adverse events of ...... with neuroendocrine neoplasms.
@en
P2093
Arthur Jochems
Aviral Singh
Daniel Kaemmerer
Dieter Hörsch
Dirk Mueller
Franz C Robiller
Harshad R Kulkarni
Holger Franz
Karin Niepsch
Merten Hommann
P2860
P304
16932-16950
P356
10.18632/ONCOTARGET.24524
P407
P577
2018-02-15T00:00:00Z